Table 2.

Adjusted odds ratios and 95% confidence intervals for initiating a selective COX-2 inhibitor by age, gender and cardiovascular (CV) risk pre and postrofecoxib withdrawal

	Nimesulide vs. nsNSAIDs*	Celecoxib vs. nsNSAIDs*	Rofecoxib vs. nsNSAIDs*
Female vs. male*	1.09 (1.06, 1.12)	1.15 (1.11, 1.19)	1.14 (1.10, 1.19)
	1.11 (1.09, 1.14)	1.15 (1.10, 1.20)	–
>65 vs. <65 years*	1.68 (1.63, 1.73)	2.76 (2.65, 2.86)	2.32 (2.21, 2.42)
	1.63 (1.58, 1.67)	2.21 (2.10, 2.32)	–
CV risk vs. no CV risk*	1.28 (1.25, 1.32)	1.72 (1.67, 1.79)	1.61 (1.54, 1.69)
	1.32 (1.28, 1.35)	1.70 (1.60, 1.79)	–

^*Indicates the reference category in the logistic regression. Postwithdrawal results indicated in bold. nsNSAID, Nonselective nonsteroidal anti-inflammatory drug.